Global Brain Cancer Therapeutics Market Research Report: Forecast (2025-2030)

Brain Cancer Therapeutics Market Size - By Type (Glioblastoma, Meningioma, Pituitary Tumors, Others), By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Other), By Distribu......tion Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Others Read more

  • Healthcare
  • Apr 2025
  • 192
  • PDF, Excel, PPT

Market Definition

Brain cancer therapeutics refers to the medical treatment and strategies used to manage and treat brain cancer which involve malignant growth or tumors in the brain. These therapies aim to eliminate the growth of the tumor in the brain.

Market Insights & Analysis: Global Brain Cancer Therapeutics Market (2025-30):

The Global Brain Cancer Therapeutics Market size was valued at around USD 3.3 billion in 2024 and is projected to reach USD 5.1 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.3% during the forecast period, i.e., 2025-30. This market is undergoing significant growth, driven by multiple factors like the robust pipeline of new drugs and therapies undergoing clinical trials and the rising awareness about brain tumor treatments. A strong pipeline of innovative medicines in clinical trial stages indicates how pharmaceutical companies and various research institutions are committed to addressing medical needs. For instance, as per the Ivy Brain Tumor Center in 2024, about 1.4 million individuals worldwide are living with malignant brain tumors, while up to 256,000 new cases may occur in the coming years. Public awareness about brain tumors as life-threatening conditions is playing a vital role in opening up windows of early detection and better treatment outcomes. The increasing awareness of the symptoms of brain tumors allows for early diagnosis, and improved survival chances of patients.

Report Coverage Details
  Historical Years   2020-23
  Base Years
  2024
  Forecast Years
  2025-30
  Market Value in 2024   USD 3.3 Billion
  Market Value in 2030   USD 5.1 Billion
  CAGR (2025-30)   7.3%
  Leading Region   North America
  Top Key Players Amgen Inc., AstraZeneca PLC, Bayer AG, Kazia Therapeutics Ltd., Eisai Co., Ltd., F. Hoffmann-La Roche Ltd., GSK plc, Johnson & Johnson, Merck & Co. Inc. Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Genentech, Inc., NantOmics, Thermo Fisher Scientific Inc. and others
  Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation,
  • Recent Strategic Moves by Companies,
  • Primary Stakeholders,
  • Analysis of Import and Export Trends,
  • Competitive Landscape Assessment,
  • Emerging Opportunities,
  • Market Trends and Indicators

 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Governments across the globe are also increasing support for brain cancer treatments. The global government's focus on expanding healthcare infrastructure and subsidizing treatment costs is pivotal in driving the brain cancer therapeutics market. For instance, in the United States, Medicare, Medicaid, and the VA ensure proper and accessible treatment and patient services. In 2024 FDA approved a drug by Johns Hopkins discovery for the treatment of brain cancer called IDH Mutant low-grade glioma. Also, funding dedicated to brain cancer research and related awareness efforts reflects the importance of governments’ aim in dealing with this critical health issue. The Bolstering Research and Innovation Now (BRAIN) Act is a vast push for increased funding in research, collaboration, and awareness for brain tumors. The National Cancer Institute and the National Institutes of Health also play a major role in funding and supporting brain cancer research. These organizations dedicate significant funds to developing innovative therapies and improving diagnostic techniques, which continues to drive further growth in the market.

Additionally, the European Union currently has a program called Horizon Europe that allocates very large amounts of money for research in brain tumors, thus impelling cross-border cooperation and innovation. Also, the EU Mission: Cancer further aims to improve the lives of over 3 million cancer patients by 2030. These government initiatives and policies go a long way toward improving brain cancer therapy, ensuring accessibility to treatment worldwide, and improving outcomes for patients. In India, several schemes like Ayushman Bharat help economically vulnerable populations with health insurance coverage ensuring that quality health care is obtained for them. In 2025, the Indian government formally announced its commitment to the establishment of more than 200 daycare cancer centers for patients in diverse states during Budget 2025. These daycare centers will range from many different districts and provide treatment and support to cancer patients.

  1. Market Segmentation
  2. Introduction
    1. Market Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Brain Cancer Therapeutics Market Trends & Developments
  5. Global Brain Cancer Therapeutics Market Dynamics
    1. Drivers
    2. Challenges
  6.  Global Brain Cancer Therapeutics Market Regulations, Policies & Standards
  7.  Global Brain Cancer Therapeutics Market Hotspot & Opportunities
  8.  Global Brain Cancer Therapeutics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Size & Analysis
      1. By Type
        1. Glioblastoma -Market Size & Forecast 2020-2030, USD Million
        2. Meningioma-Market Size & Forecast 2020-2030, USD Million
        3. Pituitary Tumors-Market Size & Forecast 2020-2030, USD Million
        4. Others-Market Size & Forecast 2020-2030, USD Million
      2. By Therapy
        1. Chemotherapy-Market Size & Forecast 2020-2030, USD Million
        2. Immunotherapy-Market Size & Forecast 2020-2030, USD Million
        3. Targeted Therapy-Market Size & Forecast 2020-2030, USD Million
        4. Other-Market Size & Forecast 2020-2030, USD Million
      3. By Distribution Channel
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      5. By Company
        1. Competition Characteristics
        2. Revenue Shares
  9. North America Brain Cancer Therapeutics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2020-2030, USD Million
      2. By Therapy - Market Size & Forecast 2020-2030, USD Million
      3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
      4. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    4. Canada Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    5. Mexico Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
  10. South America Brain Cancer Therapeutics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2020-2030, USD Million
      2. By Therapy - Market Size & Forecast 2020-2030, USD Million
      3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
      4. By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    3. Brazil Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    4. Argentina Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
  11. Europe Brain Cancer Therapeutics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2020-2030, USD Million
      2. By Therapy - Market Size & Forecast 2020-2030, USD Million
      3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
      4. By Country
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    3. Germany Brain Cancer Therapeutics Market, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    4. The UK Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    5. France Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    6. Italy Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    7. Spain Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
  12. The Middle East & Africa Brain Cancer Therapeutics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2020-2030, USD Million
      2. By Therapy - Market Size & Forecast 2020-2030, USD Million
      3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
      4. By Country
        1. Saudi Arabia
        2. The UAE
        3. South Africa
        4. Rest of the Middle East & Africa
    3. Saudi Arabia Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    4. The UAE Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    5. South Africa Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
  13. Asia-Pacific Brain Cancer Therapeutics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2020-2030, USD Million
      2. By Therapy - Market Size & Forecast 2020-2030, USD Million
      3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
      4. By Country
        1. China
        2. Japan
        3. India
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
    3. China Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    4. Japan Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1.       By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    5. India Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    6. South Korea Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
    7. Australia Brain Cancer Therapeutics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type- Market Size & Forecast 2020-2030, USD Million
        2. By Therapy - Market Size & Forecast 2020-2030, USD Million
        3. By Distribution Channel-  Market Size & Forecast 2020-2030, USD Million
  14. Brain Cancer Therapeutics Market Key Strategic Imperatives for Success & Growth
    1. Company Profile
      1. Amgen Inc.
        1. Business Description
        2.  Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. AstraZeneca PLC
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Bayer AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Kazia Therapeutics Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5.  Eisai Co., Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. F. Hoffmann-La Roche Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7.  GSK plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Johnson & Johnson
        1. Business Description
        2.  Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9.  Merck & Co. Inc.
        1. Business Description
        2.  Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Novartis AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Pfizer Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Bristol-Myers Squibb Company
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Genentech, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. NantOmics
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15.  Thermo Fisher Scientific Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  15. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying Inquire Before Buying
Related Reports
Talk to our Consultant Talk to our Consultant
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization Request Customization